IONS News
Ionis Pharmaceuticals, Inc.
$44.27
-$1.13(-2.49%)
42
Overall
40
Value
36
Tech
52
Quality
Market Cap
$7.54B
Volume
2.27M
52W Range
$42.08 - $86.74
Target Price
$79.90
IONS news: the latest Ionis Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest IONS News
- Ionis boosted by FDA approval of hepatitis B therapyTipRanks Auto-Generated Newsdesk · Oct 21, 2026
- Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Unicycive Therapeutics (UNCY)TipRanks Newsroom · Oct 21, 2026
- 3 Healthcare Stocks with Strong Buy Ratings and Double-Digit UpsideSukanya Varma · Oct 21, 2026
- Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Maze Therapeutics, Inc. (MAZE) and Abbott Laboratories (ABT)TipRanks Newsroom · Oct 21, 2026
- Amprius, Viking, Regeneron, Ionis, Crispr Trending With AnalystsTipRanks Weekend Auto-Generated Newsdesk · Oct 17, 2026
- Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Ionis Pharmaceuticals (IONS)TipRanks Newsroom · Oct 15, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Oct 9, 2026
- AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?Ran Melamed · Oct 7, 2026
- Ionis Advances CHAMPION Phase 3 Trial in Angelman Syndrome, Raising Long‑Term Optionality for IONS InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 28, 2026
- Analysts Offer Insights on Healthcare Companies: Immunovant (IMVT) and Ionis Pharmaceuticals (IONS)TipRanks Newsroom · Sep 23, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IONS | $44.27 | -2.5% | 2.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ionis Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW